O15496 (PA2GX_HUMAN) Homo sapiens (Human)
Group 10 secretory phospholipase A2 UniProtKBInterProSTRINGInteractive Modelling
165 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
7 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Discovery of a novel secreted phospholipase A2 (sPLA2) inhibitor. | monomer | 1×CA; 5×DMS; 7×PEG; 1×9JH; | ||||
Assess | ||||||
Indole-2 carboxamides as selective secreted phospholipase A2 type X (sPLA2-X) inhibitors | monomer | 1×CA; 4×DMS; 1×AYN; 4×PEG; 2×CL; | ||||
Assess | ||||||
CARBOXYLIC ESTER HYDROLASE, P 1 21 1 SPACE GROUP | monomer | 1×CA; | ||||
Assess | ||||||
CARBOXYLIC ESTER HYDROLASE, C 2 2 21 space group | monomer | 1×CA; 3×MPD; | ||||
Assess | ||||||
Indole-2 carboxamides as selective secreted phospholipase A2 type X (sPLA2-X) inhibitors | monomer | 1×CA; 1×AYZ; 2×DMS; 4×PEG; | ||||
Assess | ||||||
Secreted phospholipase A2 type X in complex with ligand | monomer | 1×CA; 2×EM8; 1×PEG; 1×DMS; | ||||
Assess | ||||||
Novel pyrazole series of group X Secretory Phospholipase A2 (sPLA2-X) inhibitors | monomer | 1×CA; 2×1PE; 4×DMS; 1×TJM; 3×PEG; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
6g5j.1.A | monomer | 0.82 | 1×CA; 2×EM8; | 100.00 | ||
Assess |